Patents Represented by Attorney, Agent or Law Firm Daniel W. Collins
-
Patent number: 5693611Abstract: Provided are pharmaceutical formulations, and methods of inhibiting fungal and parasitic activity using a compound of formula I ##STR1## wherein: R', R", R'", R.sup.x1, R.sup.x2, R.sup.y1, R.sup.y2, R.sup.y3, R.sup.y4, and R.sup.0 are as defined herein below;R.sup.2 is a novel acyl side chain. Also provided are novel formulations and methods of inhibiting fungal and parasitic activity.Type: GrantFiled: January 17, 1997Date of Patent: December 2, 1997Assignee: Eli Lilly and CompanyInventors: Stacy Kay Henle, William Wilson Turner
-
Patent number: 5677423Abstract: A process for removing .beta.-hydroxy groups from .beta.-hydroxy-containing compounds is disclosed. The process involves the use of a retro-aldol-promoting reagent selected from the group of trimethylamine-N-oxide, triethylamine-N-oxide, trimethylamine-N-oxide-hydrate, and trimethylamine-hydrate and requires dissolution of the substrate in an aprotic solvent and reaction under elevated temperatures. The process is broadly applicable to a variety of substrates including complex cyclic peptides, linear peptides, and non-peptides.Type: GrantFiled: December 10, 1996Date of Patent: October 14, 1997Assignee: Eli Lilly and CompanyInventor: Michael J. Rodriguez
-
Patent number: 5672618Abstract: The present invention discloses compounds that are highly isozyme selective protein kinase C beta-1 and beta-2 isozyme inhibitors. Accordingly, the present invention provides a method of selectively inhibiting protein kinase C isozymes beta-1, and beta-2. As isozyme selective inhibitors of beta-1 and beta-2, the compounds are therapeutically useful in treating conditions associated with diabetes mellitus and its complications, as well as other disease states associated with an elevation of the beta-1 and beta-2 isozyme.Type: GrantFiled: May 25, 1995Date of Patent: September 30, 1997Assignee: Eli Lilly and CompanyInventors: William F. Heath, Jr., John H. McDonald, III, Michael Paal, Theo Schotten, Wolfgang Stenzel
-
Patent number: 5514706Abstract: This invention provides novel compounds and pharmaceutical methods comprising the administration of a compound of the Formula I: ##STR1## wherein n, m, R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are variables.Type: GrantFiled: November 21, 1994Date of Patent: May 7, 1996Assignee: Eli Lilly and CompanyInventors: Samantha J. Ambler, William F. Heath, Jr., Jai P. Singh, Colin W. Smith, Lawrence E. Stramm
-
Patent number: 5407835Abstract: Immunoassay methods and reagents for the specific quantification of amitriptyline or nortriptyline in a test sample are disclosed employing antibodies prepared with amitriptyline or nortriptyline derivatives of the Formula III: ##STR1## wherein for amitriptyline, R is CH.sub.3, and for nortriptyline, R is H. The present invention also describes the synthesis of unique fluorescein tracers of the structure of Formula IV and Formula V: ##STR2## wherein for a specific amitriptyline immunoassay, W.sub.1 is a heteroatom linked to the aromatic ring at the 2 or 3 position, and for a specific nortriptyline immunoassay, W.sub.2 is two heteroatoms linked together and attached to the aromatic ring at the 2 or 3 position, and wherein Q is a detectable moiety, preferably fluorescein or a fluorescein derivative.Type: GrantFiled: July 24, 1992Date of Patent: April 18, 1995Assignee: Abbott LaboratoriesInventors: Maciej Adamczyk, Jeffrey R. Fishpaugh, Donald Johnson, Daryl E. Hartter
-
Patent number: 5376313Abstract: A plastic assay cuvette having the desired optical properties for the analysis of a test sample or reaction mixture thereof, and a method for making such plastic assay cuvette, are described. The optical properties of the plastic assay cuvette are substantially the same as the optical properties of glass wherein low birefringence throughout the optical read region thereof is provided. When used for the analysis of a test sample or reaction mixture thereof, such as in fluorescence polarization assays and absorbance assays, the plastic assay cuvette provides accurate and reproducible results while, at the same time, provides a low-cost disposable assay cuvette which can be used in place of conventional glass assay cuvettes.Type: GrantFiled: July 20, 1992Date of Patent: December 27, 1994Assignee: Abbott LaboratoriesInventors: William J. Kanewske, III, James A. Vaught, Richard L. Vickstrom, Frederic L. Clark, Gilbert Clift, Kendall B. Hendrick, Peter A. Lagocki, Richard R. Martin, James E. Mitchell, Larry E. Moore, Charles D. Pennington, Edna S. Walker, B. Jane Smith, Apparao Tayi, David A. Yost
-
Patent number: 5374518Abstract: A mouse monoclonal antibody is provided which detects HIV-2 seropositive individuals and differentiates them from HIV-1 seropositive individuals. The monoclonal antibody is specific for an epitope of HIV-2 gp41 which lies outside the characterized immunodominant region. The epitope recognized by the monoclonal antibody has the amino acid sequence HTTVPW.Type: GrantFiled: September 28, 1992Date of Patent: December 20, 1994Assignee: Abbott LaboratoriesInventors: Jeffrey C. Hunt, Virender K. Sarin, Sushil G. Devare, Ilse I. E. Tribby, Suresh M. Desai, James M. Casey
-
Patent number: 5358691Abstract: An automated, continuous and random access analytical system, having apparatus and methodology capable of simultaneously performing multiple assays of liquid samples using different assay methodologies, and providing continuous and random access while performing a plurality of different assays on the same or different samples during the same time period, is disclosed. A method is also disclosed of operating an automated continuous and random access analytical system capable of simultaneously effecting multiple assays of a plurality of liquid samples wherein scheduling of various assays of the plurality of liquid samples is followed by creating a unit dose disposable and separately transferring a first liquid sample and reagents to a reaction vessel without initiation of an assay reaction sequence, followed by physical transfer of the unit dose disposable to a processing workstation, whereby a mixture of the unit dose disposable reagents and sample are achieved during incubation.Type: GrantFiled: September 24, 1993Date of Patent: October 25, 1994Assignee: Abbott LaboratoriesInventors: Frederic L. Clark, Gilbert Clift, Kendall B. Hendrick, William J. Kanewske, III, Peter A. Lagocki, Richard R. Martin, James E. Mitchell, Larry W. Moore, Charles D. Pennington, Edna S. Walker, B. Jane Smith, Apparao Tayi, James A. Vaught, David A. Yost
-
Patent number: 5340750Abstract: Immunoassay methods and reagents for the specific quantification of imipramine or desipramine in a test sample are disclosed. The measurement of imipramine or desipramine is accomplished in a specific immunoassay employing antibodies prepared with imipramine or desipramine derivatives of the Formula III: ##STR1## wherein P is an immunogenic carrier material, X is two heteroatoms, Y is a linking group comprising from 1 to 6 carbon atoms and P is an immunogenic carrier material, and wherein for imipramine, R is CH.sub.3, and for desipramine, R is H.The present invention also describes the synthesis of unique labeled reagents of the structure of the Formula IV: ##STR2## wherein Z is a linking group comprising 1 to 4 carbon atoms and 0 to 2 heteroatoms and Q is a detectable moiety, preferably fluorescein or a fluorescein derivative, and wherein for imipramine, R.sub.1 is CH.sub.3, and for desipramine, R.sub.1 is H.Type: GrantFiled: July 24, 1992Date of Patent: August 23, 1994Assignee: Abbott LaboratoriesInventors: Maciej Adamczyk, Charles A. Harrington, Donald Johnson
-
Patent number: 5336622Abstract: A fluorescence polarization immunoassay for flecainide and tracers therefor are disclosed.Type: GrantFiled: April 11, 1989Date of Patent: August 9, 1994Assignee: Abbott LaboratoriesInventor: Daniel F. Heiman
-
Patent number: 5332661Abstract: Immunoassay methods and reagents for the quantification of total doxepins (i.e., E-doxepin, Z-doxepin, E-desmethyldoxepin, and Z-desmethyldoxepin) in a test sample are disclosed. The quantification of total doxepins is accomplished in an immunoassay employing antibodies and labeled reagents prepared with doxepin derivatives of the Formula II: ##STR1## wherein Y--Z can be C.dbd.CH or N--CH.sub.2, R.sub.` is a linking group, R.sub.2 can be H or CH.sub.3, and Q can be a detectable moiety or an immunogenic carrier material. The antibody reagent comprises antibodies which are capable of binding to total doxepins and which are produced with one or more immunogens prepared from the doxepin derivative of Formula II, and the labeled reagent is also prepared from the doxepin derivative of Formula II.Type: GrantFiled: July 24, 1992Date of Patent: July 26, 1994Assignee: Abbott LaboratoriesInventors: Maciej Adamczyk, Jeffrey R. Fishpaugh, Donald Johnson, Robert E. Hruska
-
Patent number: 5312737Abstract: Disclosed is a method of producing fusion proteins, particularly HCV fusion proteins, wherein one part of the fusion protein is formed from the bacterial protein CKS.Type: GrantFiled: February 14, 1992Date of Patent: May 17, 1994Assignee: Abbott LaboratoriesInventors: Timothy J. Bolling, Wlodzimierz Mandecki
-
Patent number: 5272260Abstract: Novel pyrene-trisulfonate derivatives and the use thereof in a method for the determination of glycohydrolytic enzyme activity are provided. The method comprises the steps of (a) forming a test solution comprising a test sample containing the glycohydrolytic enzyme and a pyrene-trisulfonate derivative of the present invention, wherein the derivative is hydrolyzed by the glycohydrolytic enzyme to result in the formation of free 8-hydroxy-1,3,6-pyrene trisulfonate as a function of, and which can be correlated to, the amount of the glycohydrolytic enzyme present in the test sample, and (b) measuring and correlating either the intensity of fluorescence, or the optical density, of the test solution to the presence or amount of the glycohydrolytic enzyme in the test sample. A preferred pyrene-trisulfonate derivative is pyrene-1,3,6-trisulfonic acid) 8-.beta. -D-glucuronide for the determination of .beta.-D-glucuronidase for the diagnosis of periodontal disease.Type: GrantFiled: January 29, 1992Date of Patent: December 21, 1993Assignee: Abbott LaboratoriesInventors: Mark R. Pope, Christopher Bieniarz
-
Patent number: 5246354Abstract: A valveless metering pump includes a simultaneously reciprocating and rotating piston. The pump head includes radially spaced coplanar ports for drawing and dispensing fluids as the piston rotates sequentially past the ports. The reciprocating stroke of the piston is controlled by adjusting the axis of the piston relative to the drive axis. The pump is designed so that the angular relationship of the ports also can be adjusted relative to the piston to balance the output at the sequential ports. The plurality of adjustments provide a valveless, positive displacement metering pump which is reliable and dependable for dispensing precise volumes of fluid through a plurality of outlet ports.Type: GrantFiled: January 31, 1991Date of Patent: September 21, 1993Assignee: Abbott LaboratoriesInventor: Guillermo P. Pardinas
-
Patent number: 5244630Abstract: A disposable device suitable for performing automated solid-phase diagnostic assays which employs microparticles to complex an analyte and where the microparticle complex becomes retained and immobilized on a fibrous matrix such that the presence of analyte on the microparticles can be detached by optical means.Type: GrantFiled: October 23, 1989Date of Patent: September 14, 1993Assignee: Abbott LaboratoriesInventors: Omar S. Khalil, Charles F. Hanna, Denise G. Huff, Thomas F. Zurek
-
Patent number: 5229268Abstract: A method for performing a diagnostic immunoassay by a solid phase separation. To a reaction mixture of a test sample and labeled antibody, which forms a complex of any analyte present in the test sample, is added a solid phase material having a compound capable of binding any excess labeled antibody. The solid phase material is chosen to rapidly settle whereby a solid and liquid phase is formed. The liquid phase can then be extracted to measure the amount of analyte-labeled antibody present therein.Type: GrantFiled: November 24, 1987Date of Patent: July 20, 1993Assignee: Abbott LaboratoriesInventors: Terry A. Pry, Edward N. Granados, Philip M. Hill
-
Patent number: 5191066Abstract: A process for producing a derivatized immunoglobulin and conjugates prepared therewith are provided. The derivatized immunoglobulin is produced by introducing sulfhydryl groups in the Fc region of an immunoglobulin wherein the Fab portion of the immunoglobulin is not altered. The derivatized immunoglobulin is used to prepare conjugates with various detectable moieties wherein a controlled distance exists between the Fc region of the immunoglobulin and the detectable moiety. The conjugates are particularly useful for performing immunoassays, and exhibit improved longevity, specificity and sensitivity.Type: GrantFiled: December 7, 1990Date of Patent: March 2, 1993Assignee: Abbott LaboratoriesInventors: Christopher Bieniarz, Mazhar Husain, Howard E. Bond
-
Patent number: 5158873Abstract: A rapid and specific method and reagent for determining LD-1 isoenzyme in biological fluids by incorporating a chaotropic agent, such as sodium perchlorate, into an LDH assay reagent system. The chaotropic agent produces an immediate inactivation of the LDH isoenzymes containing one or more `M` type subunits while the LTD-1 isoenzyme remains stable and is simultaneously measured.Type: GrantFiled: November 6, 1989Date of Patent: October 27, 1992Assignee: Abbott LaboratoriesInventors: William A. Abbott, David A. Yost, Rita S. Byrne
-
Patent number: 5151518Abstract: A process for the N-arylation of isatins with organo bismuth reagents is disclosed.Type: GrantFiled: November 30, 1989Date of Patent: September 29, 1992Assignee: Abbott LaboratoriesInventors: James E. Dombrowski, Phillip G. Mattingly
-
Patent number: D349861Type: GrantFiled: July 20, 1992Date of Patent: August 23, 1994Assignee: Abbott LaboratoriesInventors: William J. Kanewske, Max K. Yoshimoto, Brett C. Lovelady